Cannabinoid Drugs Can Directly Inhibit HIV In Late-Stage AIDS
Mount Sinai School of Medicine researchers have discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immunodeficiency virus (HIV) found in late-stage AIDS, according to new findings published online in the journal PLoS ONE. This is the first study to reveal how the marijuana receptors found on immune cells-called cannabinoid receptors CB1 and CB2-can influence the spread of the virus. "We knew that cannabinoid drugs like marijuana can have a therapeutic effect in AIDS patients, but did not understand how they influence the spread of the virus itself," said study author Cristina Costantino, PhD, Postdoctoral Fellow in the Department of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine.
- Dr. Cristina Costantino, Postdoctoral Fellow, Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine
Learn more: http://www.news-medical.net/news/20120321/Cannabinoid-drugs-can-directly-inhibit-HIV-in-late-stage-AIDS.aspx
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
Oct 30, 2024 View All Press Releases
Mount Sinai Researchers Publish Critical Examination of New Brain Tumor Drug
Sep 23, 2024 View All Press Releases